Bridgeway Capital Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Buy |
188,200
+74,400
| +65% | +$251K | 0.02% | 731 |
|
|
2025
Q1 | $439K | Sell |
113,800
-14,600
| -11% | -$56.4K | 0.01% | 766 |
|
|
2024
Q4 | $792K | Sell |
128,400
-107,200
| -46% | -$661K | 0.02% | 716 |
|
|
2024
Q3 | $1.27M | Hold |
235,600
| – | – | 0.03% | 624 |
|
|
2024
Q2 | $789K | Buy |
235,600
+89,700
| +61% | +$300K | 0.02% | 751 |
|
|
2024
Q1 | $588K | Hold |
145,900
| – | – | 0.01% | 878 |
|
|
2023
Q4 | $387K | Buy |
145,900
+65,400
| +81% | +$173K | 0.01% | 1004 |
|
|
2023
Q3 | $190K | Buy |
+80,500
| New | +$190K | ﹤0.01% | 1112 |
|